Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hantech Bio-Technology Co., Ltd. (1294:TWSE), powered by AI.
Hantech Bio-Technology Co., Ltd. is currently trading at $80.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hantech Bio-Technology Co., Ltd. on Alpha Lenz.
View Hantech Bio-Technology Co., Ltd.'s valuation metrics on Alpha Lenz.
“Hantech Bio-Technology Co., Ltd.'s ROE is 16.9%. Explore profitability and growth together.”
Ask for details →Hantech Bio-Technology Co., Ltd. is a biotechnology company specializing in the manufacture and sale of health supplement products and functional beverages. Its core business revolves around developing dietary supplements offered in gel, liquid, and powder forms—often delivered via innovative pouch packaging including patented aluminum foil and retort designs. Serving both OEM and ODM needs, Hantech provides tailored solutions for partners seeking bespoke health food products, such as collagen drinks, lutein supplements, iron-infused drinks, pearl powder, and Guilu (tortoise shell and deer antler) essence. Established in 2007 and headquartered in Yuanlin City, Taiwan, the company adheres to international standards like ISO22000 and GMP, ensuring high product quality. Hantech’s offerings impact the consumer staples sector, addressing growing market demand for nutraceuticals and functional foods within Taiwan and exporting to China, Southeast Asia, America, and beyond. Its market significance is marked by a comprehensive portfolio of packaged health foods, innovative delivery systems, and a focus on research-driven product development.
“Hantech Bio-Technology Co., Ltd.'s ROE is 16.9%. Explore profitability and growth together.”
Ask for details →Hantech Bio-Technology Co., Ltd. (ticker: 1294) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods).
The current price is 80 with a P/E ratio of -x and P/B of -x.
ROE is 16.89% and operating margin is 22.29%. Annual revenue is $779M.